The weekly litigation news digest is live. Subscribe now

IP Verse

Novel Crispr Enzymes And Systems - EP3604532

The patent EP3604532 was granted to Massachusetts Institute OF Technology on May 1, 2024. The application was filed on Jun 17, 2016 under application number EP19171732A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3604532

MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Application Number
EP19171732A
Filing Date
Jun 17, 2016
Status
Granted And Under Opposition
Mar 29, 2024
Publication Date
May 1, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
COOLEY UKFeb 3, 2025SCHIWECK WEINZIERL KOCH PATENTANWALTE PARTNERSCHAFT MBBADMISSIBLE
JAMES POOLEFeb 3, 2025CARPMAELS & RANSFORDADMISSIBLE
MAIWALDJan 31, 2025MAIWALDADMISSIBLE
GRUND IPG PATENTANWALTE UND SOLICITOR PARTG MBBNov 13, 2024GRUNDADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONWO2014093712
OPPOSITIONWO2014191521
OPPOSITIONWO2016166340
OTHERWO2014191521
OTHERWO2016166340
OTHERWO2021133977
SEARCHWO2016205749
SEARCHWO2016205764

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents